A preclinical design approach for translation of biohybrid photosensitive nanoplatform for photodynamic therapy of breast cancer.

J Control Release

Laboratory of Microfluidics and Medical Microsystems, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Orthopedic Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran; Clinical Research Unit, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address:

Published: December 2024

AI Article Synopsis

  • - The study presents a two-phase approach to develop and characterize novel hybrid nano-photosensitizers for targeting breast cancer, integrating molecular simulations with laboratory and animal experiments for improved model accuracy.
  • - In the first phase, researchers used artificial intelligence and molecular docking to identify pharmacokinetic weaknesses and synthesized biohybrid nanoplatforms, assessing their stability in vivo.
  • - The second phase optimized photodynamic treatment variables and demonstrated that the optimized nano-photosensitizer effectively killed triple-negative cancer cells in both static and dynamic cultures, indicating a promising strategy for enhancing cancer treatment.

Article Abstract

Translating photodynamic therapy research into practice with high efficacy should follow characterization and optimization steps in an integrated process. In this way, integration of molecular-based simulations with in vitro and in vivo studies to produce more accurate models with higher prediction precision is inevitable. This study reports on the development a two-phase approach to design and synthesize, and characterize novel hybrid nano-photosensitizers to target breast cancer using molecular docking, microfluidic-based testing and animal studies. In the first phase, using pkCSM artificial intelligence tool and molecular docking, pharmacokinetic weaknesses of photoprotoporphyrin and its retention potential within albumin protein were identified. Biohybrid photosensitive nanoplatform were then synthesized using opto-microfluidics and characterized. In addition, an in-vivo method was used to qualitatively evaluate the opto-biological stability of the final optimized biohybrid nanoplatform. At the second phase, variables of photodynamic treatment were firstly optimized using design of experiment method for the optimized biohybrid photosensitive nanoplatform. Then, on-chip photodynamic studies were carried out in static and dynamic conditions. Results revealed that optimized biohybrid photosensitive nanoplatform as a nano-photosensitizer induced significant death of triple negative human cancer cells in static and dynamic cell cultures under optimized irradiation conditions. Consequently, the presented multiphase study that combined in-silico simulations with microfluidic-based synthesis and characterizations of nano-photosensitizers provided a more convergent model for development of efficacious cancer treatment for photodynamic therapy applications.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2024.12.021DOI Listing

Publication Analysis

Top Keywords

biohybrid photosensitive
16
photosensitive nanoplatform
16
photodynamic therapy
12
optimized biohybrid
12
breast cancer
8
molecular docking
8
static dynamic
8
biohybrid
5
nanoplatform
5
photodynamic
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!